Tough but reasonable: why it’s worth getting a dialogue going with Singapore regulators
This article was originally published in Clinica
Executive Summary
Singapore has a reputation for being a tough nut to crack when it comes to medical device regulatory access, but is this justified? Amanda Maxwell reports on the latest information to emerge at an Informa meeting earlier this month on Medical Device and IVD Regulations in Asia Pacific
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.